MediPharm Labs (TSE:LABS) Trading Up 7.1% – Should You Buy?

MediPharm Labs Corp. (TSE:LABSGet Free Report) shares traded up 7.1% during mid-day trading on Tuesday . The stock traded as high as C$0.08 and last traded at C$0.08. 123,212 shares changed hands during mid-day trading, a decline of 66% from the average session volume of 362,070 shares. The stock had previously closed at C$0.07.

MediPharm Labs Stock Performance

The stock’s 50 day moving average is C$0.07 and its 200-day moving average is C$0.07. The company has a market cap of C$35.27 million, a P/E ratio of -2.93 and a beta of 0.88. The company has a current ratio of 3.21, a quick ratio of 3.10 and a debt-to-equity ratio of 1.45.

About MediPharm Labs

(Get Free Report)

MediPharm Labs Corp., a pharmaceutical company, produces and sells pharmaceutical-quality cannabis oil and concentrates, and advanced derivative products in Canada and internationally. The company formulates, processes, packages, and distributes cannabis extracts and advanced cannabinoid-based products.

See Also

Receive News & Ratings for MediPharm Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MediPharm Labs and related companies with MarketBeat.com's FREE daily email newsletter.